• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    H

    Hospital Universitario Doctor Peset

    EST. 1989
    2,465论文总数
    4.2万引用总数

    论文量&引用量时间轴

    机构学者

    论文(2465)

    年份
    起
    –
    止
    排序
    1Trends in Hepatitis C Virus Infection Prevalence among People with HIV in Spain over 2 Decades (2002-2023)
    Juan Berenguer,Chiara Fanciulli, María M Arcos, María J Vivancos,Pere Domingo,Asunción Hernando, Julia Barrado,Pablo Ryan, Jordi Navarro,Rosario Palacios, Luis E Morano, José A Iribarren,

    BACKGROUND:Hepatitis C virus (HCV) has significantly impacted people with human immunodeficiency virus (HIV). Harm reduction programs, changing transmission patterns, and direct-acting antivirals (DAAs) have profoundly altered HIV/HCV coinfection trends. This study evaluates HCV prevalence among people with HIV in Spain over 2 decades. METHODS:We conducted 9 cross-sectional studies (2002-2023) in 39-43 centers. Sampled individuals were randomly sampled from people with HIV actively followed up at these centers, with proportional allocation. Main outcomes included the prevalence of anti-HCV antibody and active HCV infection (HCV RNA--positive result). RESULTS:The reference population ranged from 31 800 to 47 006, with sample sizes of 1260-1867. HIV transmission patterns shifted from 2002 to 2023, with injection drug use decreasing from 55% to 21% and the proportion of men who have sex with men increasing from 17% to 46%. HCV seroprevalence fell from 60.8% to 27.4%, and active infection from 46.3% to 0.9%. In the DAA era (2015-2023), active HCV infection dropped by 100% in heterosexuals, 94% in people who inject drugs, and 71% in men who have sex with men. Treatment uptake increased from 23% in 2002 to 99% by 2023 with all-oral DAAs. The prevalence of cirrhosis among active HCV cases peaked at 23.1% in 2015 but fell to 0% by 2021. Among those achieving sustained virologic response, cirrhosis prevalence was 20.4% in 2023. CONCLUSIONS:HIV/HCV coinfection has drastically declined in Spain, with active HCV infection prevalence <1% since 2021. DAAs were pivotal in this achievement. However, cirrhosis remains a concern among those with sustained virologic response. Ongoing surveillance and prevention efforts are essential to sustain these gains and address residual risks.

    2026Clinical infectious diseases an official publication of the Infectious Diseases Society of America(2026)引用:6
    引用
    AI阅读
    加入学术空间
    2GPT-4o and OpenAI O1 Performance on the 2024 Spanish Competitive Medical Specialty Access Examination: Cross-Sectional Quantitative Evaluation Study.
    Pau Benito, Mikel Isla-Jover, Pablo González-Castro, Pedro José Fernández Esparcia, Manuel Carpio, Iván Blay-Simón, Pablo Gutiérrez-Bedia, Maria J Lapastora, Beatriz Carratalá, Carlos Carazo-Casas

    Background:In recent years, generative artificial intelligence and large language models (LLMs) have rapidly advanced, offering significant potential to transform medical education. Several studies have evaluated the performance of chatbots on multiple-choice medical examinations. Objective:The study aims to assess the performance of two LLMs-GPT-4o and OpenAI o1-on the Médico Interno Residente (MIR) 2024 examination, the Spanish national medical test that determines eligibility for competitive medical specialist training positions. Methods:A total of 176 questions from the MIR 2024 examination were analyzed. Each question was presented individually to the chatbots to ensure independence and prevent memory retention bias. No additional prompts were introduced to minimize potential bias. For each LLM, response consistency under verification prompting was assessed by systematically asking, "Are you sure?" after each response. Accuracy was defined as the percentage of correct responses compared to the official answers provided by the Spanish Ministry of Health. It was assessed for GPT-4o, OpenAI o1, and, as a benchmark, for a consensus of medical specialists and for the average MIR candidate. Subanalyses included performance across different medical subjects, question difficulty (quintiles based on the percentage of examinees correctly answering each question), and question types (clinical cases vs theoretical questions; positive vs negative questions). Results:Overall accuracy was 89.8% (158/176) for GPT-4o and 90% (160/176) after verification prompting, 92.6% (163/176) for OpenAI o1 and 93.2% (164/176) after verification prompting, 94.3% (166/176) for the consensus of medical specialists, and 56.6% (100/176) for the average MIR candidate. Both LLMs and the consensus of medical specialists outperformed the average MIR candidate across all 20 medical subjects analyzed, with ≥80% LLMs' accuracy in most domains. A performance gradient was observed: LLMs' accuracy gradually declined as question difficulty increased. Slightly higher accuracy was observed for clinical cases compared to theoretical questions, as well as for positive questions compared to negative ones. Both models demonstrated high response consistency, with near-perfect agreement between initial responses and those after the verification prompting. Conclusions:These findings highlight the excellent performance of GPT-4o and OpenAI o1 on the MIR 2024 examination, demonstrating consistent accuracy across medical subjects and question types. The integration of LLMs into medical education presents promising opportunities and is likely to reshape how students prepare for licensing examinations and change our understanding of medical education. Further research should explore how the wording, language, prompting techniques, and image-based questions can influence LLMs' accuracy, as well as evaluate the performance of emerging artificial intelligence models in similar assessments.

    2026JMIR medical education(2026)引用:2
    引用
    AI阅读
    加入学术空间
    3The Role of Digital Tools and Artificial Intelligence in Supporting Antimicrobial Stewardship: Study Protocol for a Systematic Review.
    Carlos José Cortés Sánchez, Fernando Salazar González, José María Gómez Portolés, Josefina Giménez Castellanos,Mónica Climente Martí

    INTRODUCTION:Since the post-antibiotic era, there has been significant difficulty in treating infectious diseases due to the increase in antimicrobial resistance, the scarcity of new antimicrobials, and the complexity of the healthcare system. The World Health Organization (WHO) recognized it as one of the main public health problems. To mitigate this issue, Antimicrobial Stewardship Programs (ASPs) have been established in hospital settings and in primary care, through multidisciplinary teams with specific objectives and measurable results. However, their implementation faces multiple challenges. Digital tools and artificial intelligence (AI) can enhance these ASPs, contributing to the discovery of new molecules, the identification of resistance patterns, and improvements in infection control and prevention. OBJECTIVE:To analyze the role of digital tools and AI in the interventions carried out by hospital-based ASP teams to improve established outcomes. MATERIAL AND METHODS:This protocol follows the PRISMA-P methodology and has been registered in PROSPERO (ID: CRD42024601221). A literature search will be conducted in PubMed, Scopus, and the Cochrane Library (2014-2024); gray literature will subsequently be reviewed in Google Scholar. Articles (clinical trials, interventional and observational) involving hospitalized adult patients requiring antimicrobial treatment will be included. The risk of bias will be assessed according to the study type, and methodological quality will be evaluated using the GRADE scale. Two independent researchers will perform study selection, quality assessment, and data extraction. Discrepancies will be resolved by consensus or through the intervention of a third researcher. DISCUSSION:Previous studies highlight the role of ASPs and digital tools in antimicrobial optimization. However, the difficulty and difference in the degree of implementation have also become apparent. The heterogeneity of interventions and indicators could be a limiting factor for conducting a meta-analysis. Despite these limitations, this systematic review will provide a better understanding of the potential use of digital tools and AI in hospital-based ASPs.

    2026Farmacia hospitalaria organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Ho...(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4Minimal Disease Activity As a Therapeutic Goal in Atopic Dermatitis: Predictive Factors of Sustainability in a Multicenter Cohort
    Francisco Javier Melgosa Ramos, Santiago Guillén Climent, Marta Galarreta Pascual,Antonio Martorell, María Matellanes Palacios, Juncal Roca Ginés, Javier Sabater Abad, Eduardo Bernia Petit, Víctor González Delgado

    Minimal disease activity (MDA) is an emerging therapeutic goal in atopic dermatitis (AD), providing a multidimensional assessment of disease control. We conducted a retrospective multicenter study of adults with moderate-to-severe AD receiving biologics or JAK inhibitors. MDA was defined as Eczema Area and Severity Index (EASI) ≤ 3 and Pruritus Numerical Rating Scale (NRS) ≤ 1. Univariate analyses were performed to identify baseline predictors of sustained MDA at week 52 among patients who had previously achieved MDA at week 16. Among 197 patients with week 16 data, 107 (54.3

    2026Dermatology and Therapy(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Rhinovirus/enterovirus Contribution to Respiratory-Associated Hospitalizations in Adults During Respiratory Seasons in Spain: A 6-Year Prospective Study
    Sandra S Chaves, Valérie Bosch Castells,Ainara Mira-Iglesias,Joan Puig-Barberà,F Xavier López-Labrador,Miguel Tortajada-Girbés,Mario Carballido-Fernández,Joan Mollar-Maseres, Germán Schwarz-Chávarri,Javier Díez-Domingo,Alejandro Orrico-Sánchez, Valencia Hospital Network for the Study of Influenza and other Respiratory Viruses (VAHNSI)

    BackgroundUnderstanding the burden of acute viral respiratory infection-related hospitalizations is crucial for guiding research and development. Unlike influenza, respiratory syncytial virus (RSV), or severe acute respiratory syndrome coronavirus 2, no pharmaceutical interventions exist for other respiratory viruses; therefore, their impact remains poorly characterized. This study aimed to investigate the association of current non-vaccine-preventable respiratory viruses, especially rhinovirus/enterovirus (RV/EV), on hospitalizations during the respiratory seasons.MethodsData from a prospective study that used multiplex polymerase chain reaction to conduct long-term surveillance on respiratory viruses in Valencia, Spain were analyzed. Patients aged ≥50 years hospitalized due to respiratory illness from 2014-15-2019-20 were included.ResultsRespiratory viruses were detected in 35.2% (3,755/10,675) of hospitalized patients with acute respiratory illness. Influenza and RSV accounted for 22.1% of hospitalizations, RV/EV for 7.6%, and other non-vaccine-preventable viruses for 5.4%. Adults ≥75 years had average seasonal hospitalization incidence rates more than twice those aged 65-74 years and eight times those aged 50-64-year-olds. No significant differences in severity markers were observed among patients with or without virus identified, those aged ≥75 years had a 2-3 times higher mortality rate compared to younger age groups.ConclusionsThe potential impact of respiratory viruses on hospitalization rates among older adults, particularly those aged ≥75 years, highlights the need for targeted interventions to reduce healthcare system burden. Enhanced diagnostic capabilities and the development of next-generation preventive strategies, including vaccines and therapeutics, could improve patient outcomes and strengthen the resilience of the healthcare system during respiratory virus seasons.

    2026引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2465 篇论文

    合作机构(100)

    瓦伦西亚大学合作论文 270
    Hospital Universitari i Politècnic La Fe,Instituto de Investigación Sanitaria La Fe合作论文 171
    Hospital Universitario La Paz合作论文 118
    Marqués de Valdecilla 大学医院合作论文 106
    格雷戈里奥·马拉尼翁综合大学医院合作论文 97
    Hospital de Sant Pau合作论文 94
    贝尔维特大学医院合作论文 92
    Hospital Universitario Ramón y Cajal,Comunidad de Madrid合作论文 92
    瓦尔德希布伦大学医院合作论文 85
    大学医院(新泽西州纽瓦克)合作论文 84

    机构统计